Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Glycyl-L-2-methylprolyl-L-glutamic acid

EU orphan designation number: EU/3/15/1534   
Active ingredient: Glycyl-L-2-methylprolyl-L-glutamic acid
Indication: Treatment of Rett syndrome
Sponsor: DLRC Pharma Services Ltd
Chesterfield House, Clonmannon, Ashford, Co. Wicklow, A67 WR29, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/08/2015 Orphan designation EMA/OD/056/15 (2015)5770 of 10/08/2015
14/02/2019 Transfer of orphan designation EMA/OD/0000003637 (2019)1352 of 12/02/2019